List of Spy Agent Green Kit drug patents
Spy Agent Green Kit is owned by Novadaq Tech.
Spy Agent Green Kit contains Indocyanine Green.
Spy Agent Green Kit has a total of 5 drug patents out of which 0 drug patents have expired.
Spy Agent Green Kit was authorised for market use on 21 November, 2018.
Spy Agent Green Kit is available in powder;intravenous, interstitial dosage forms.
Spy Agent Green Kit can be used as visualization of extrahepatic biliary duct attached to transplanted organ in patients 12 years and older; visualization of vessels, blood flow and tissue perfusion of transplanted organ or attached vessel in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery, visualization of vessels, blood flow and tissue perfusion in surgical flaps in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery, visualization of vessels, blood flow and tissue perfusion of vessel with arteriovenous malformation in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery, measuring time-varying change in blood in a tissue volume using modified beer-lambert law in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery, visualization of vessels, blood flow and tissue perfusion of donor organ or attached vessel in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery; visualization of extrahepatic biliary duct attached to donor organ in patients 12 years and older.
The generics of Spy Agent Green Kit are possible to be released after 04 August, 2035.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9421280 | NOVADAQ TECH | Real time imaging during solid organ transplant |
Nov, 2025
(2 years from now) | |
| US8185176 | NOVADAQ TECH | Method and apparatus for vasculature visualization with applications in neurosurgery and neurology |
Jun, 2028
(4 years from now) | |
| US8647605 | NOVADAQ TECH | Real time imaging during solid organ transplant |
Feb, 2029
(5 years from now) | |
| US8406860 | NOVADAQ TECH | Method for evaluating blush in myocardial tissue |
Apr, 2029
(5 years from now) | |
| US10631746 | NOVADAQ TECH | Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography |
Aug, 2035
(12 years from now) | |
Drugs and Companies using INDOCYANINE GREEN ingredient
Market Authorisation Date: 21 November, 2018
Treatment: Visualization of vessels, blood flow and tissue perfusion of donor organ or attached vessel in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally...
Dosage: POWDER;INTRAVENOUS, INTERSTITIAL
SPY AGENT GREEN KIT family patents
21
United States
9
European Union
7
Japan
5
Canada
4
Korea, Republic of
3
China
3
IB
2
Australia
2
Hong Kong
1
Mexico
1
Brazil
1
Russia
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic